Drugs / CHRONVAC-C
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00563173 | Oct 2007 → Apr 2010 | chronic hepatitis C virus infection | Tripep AB | Unknown | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01335711 | Apr 2011 → Jun 2012 | chronic hepatitis C virus infection | ChronTech Pharma AB | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CHRONVAC-C | “IMP: I.m. administration of 500 μg plasmid DNA vaccine CHRONVAC-C (solution for injection) administered i.m. in combination with electroporation using MedPulser® DDS on 2...” NCT01335711 ↗ |
| Modality | Vaccine | “DNA vaccine” NCT00563173 ↗ |
| Route | Intramuscular | “i.m. administration” NCT00563173 ↗ |